BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14714235)

  • 1. Unusual atrophic change after repeated arterial therapy for hepatocellular carcinoma: report of a case.
    Komori T; Sasaki Y; Yamada T; Ohigashi H; Ishikawa O; Inoue E; Ishiguro S; Seki T; Imaoka S
    Surg Today; 2004; 34(1):76-9. PubMed ID: 14714235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transarterial infusion chemotherapy using cisplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma.
    Kawaoka T; Aikata H; Takaki S; Katamura Y; Hiramatsu A; Waki K; Takahashi S; Hieda M; Toyota N; Ito K; Chayama K
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):687-94. PubMed ID: 19444503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.
    Tanaka T; Ikeda M; Okusaka T; Ueno H; Morizane C; Ogura T; Hagihara A; Iwasa S
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):683-8. PubMed ID: 17541589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case report of Vp3 hepatocellular carcinoma responding to multidisciplinary treatment].
    Miyamoto A; Kanai T; Tada M; Ebisui C; Okazaki M; Murata A; Hirai T; Murai N; Kouro T
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1732-4. PubMed ID: 9382518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
    Kirchhoff TD; Bleck JS; Dettmer A; Chavan A; Rosenthal H; Merkesdal S; Frericks B; Zender L; Malek NP; Greten TF; Kubicka S; Manns MP; Galanski M
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):259-66. PubMed ID: 17548248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of local lipiodol chemoembolization therapy in primary and secondary hepatic tumors].
    András C; Szúcs Farkas Z; Csiki Z; Gál I; Takács I; Sápy P; Péter M
    Orv Hetil; 2000 Aug; 141(32):1773-7. PubMed ID: 10979306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Two cases of long-term survival with hepatocellular carcinoma following targeting therapy with SMANCS/lipiodol].
    Inoue Y; Nakamura H
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):99-101. PubMed ID: 8546478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of hepatocellular carcinoma with tumor thrombi in the first branch of the portal vein and hepatic vein trunks treated by transcatheter hepatic arterial chemoembolization and hepatic arterial infusion chemotherapy--two years and six months follow-up].
    Haruno M; Shimamura R; Ogawa Y; Tanaka H; Sakai K; Araki K
    Gan To Kagaku Ryoho; 2005 May; 32(5):667-70. PubMed ID: 15918569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful treatment of combined intraarterial (5-fluorouracil and adriamycin and cisplatin) infusion chemotherapy for advanced hepatocellular carcinoma with multiple intrahepatic metastases and/or portal vein thrombosis--two case reports].
    Kato H; Nagano H; Ota H; Nakamura M; Wada H; Yoshioka S; Noda T; Bazarragchaa D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Murakami T; Nakamura H; Monden M
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1842-5. PubMed ID: 16315958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Eight cases of non-resectable hepatocellular carcinoma surviving for more than 3 years after Lipiodol administration].
    Shirabe K; Kanematsu T; Utsunomiya T; Furuta T; Yamagata M; Matsumata T; Sugimachi K; Yasumori K; Masuda K
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2974-7. PubMed ID: 2551238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of advanced hepatocellular carcinoma effectively treated with 5-fluorouracil and high-concentration cisplatin suspended in lipiodol by short-term hepatic arterial infusion chemotherapy].
    Yata Y; Kanda D; Takeuchi S; Hatanaka T; Iesaki K; Yoshinaga T; Kubota J; Higuchi T
    Gan To Kagaku Ryoho; 2009 Jul; 36(7):1179-81. PubMed ID: 19620813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Arterial infusion chemotherapy with SMAN CS-Lipiodol for hepatocellular carcinoma evaluation of infusion method].
    Takizawa K; Obuchi M; Honda M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2117-22. PubMed ID: 9388522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma.
    Shiraishi R; Yamasaki T; Saeki I; Okita K; Yamaguchi Y; Uchida K; Terai S; Sakaida I
    Am J Clin Oncol; 2008 Aug; 31(4):311-6. PubMed ID: 18845987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Repermeability of portal vein after intra-arterial lipiodol chemotherapy in patients with hepatocellular carcinoma. Report of 3 cases].
    Derhy S; Bessis L; Atallah R; Ajavon Y; Eisele G; Roche A
    Gastroenterol Clin Biol; 1990; 14(11):893-5. PubMed ID: 2177429
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil.
    Ishida K; Hirooka M; Hiraoka A; Kumagi T; Uehara T; Hiasa Y; Horiike N; Onji M
    Jpn J Clin Oncol; 2008 Sep; 38(9):596-603. PubMed ID: 18772170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmortem survey of bile duct necrosis and biloma in hepatocellular carcinoma after transcatheter arterial chemoembolization therapy: relevance to microvascular damages of peribiliary capillary plexus.
    Kobayashi S; Nakanuma Y; Terada T; Matsui O
    Am J Gastroenterol; 1993 Sep; 88(9):1410-5. PubMed ID: 8395764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].
    Takizawa K; Honda M; Obuchi M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of hepatocellular carcinoma with liver cirrhosis type C surviving over 2 years by repeated transarterial infusion therapy using cisplatinum].
    Miura T; Tsuboi Y; Takano T; Ozeki Y; Nakamura J; Yamada S; Miura T; Yanagi M; Takahashi T
    Gan To Kagaku Ryoho; 2009 Aug; 36(8):1347-9. PubMed ID: 19692776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of hepatocellular carcinoma with tumor thrombus in the right atrium successfully treated by arterial administration of lipiodol-SMANCS].
    Yamada K; Sato T; Yamada A; Tanaka S; Fujii S; Matuo R; Murata K; Manabe T; Oda J
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):361-4. PubMed ID: 10065101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.